MYELOABLATIVE TEMOZOLOMIDE INCREASES ANTIGEN-SPECIFIC CD8(+) T-CELL VACCINE RESPONSES AND IS REQUIRED FOR EFFICACIOUS IMMUNOTHERAPY AGAINST INTRACEREBRAL TUMORS

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Sanchez-Perez, L; Choi, B; Snyder, D; Cui, X; Schmittling, RJ; Flores, C; Johnson, L; Archer, GA; Bigner, DD; Mitchell, DA; Sampson, JH

Published Date

  • October 1, 2012

Published In

Volume / Issue

  • 14 /

Start / End Page

  • 40 - 40

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 1522-8517

Conference Name

  • 17th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO)

Conference Location

  • Washington, DC

Conference Start Date

  • November 15, 2012

Conference End Date

  • November 18, 2012